Will New Covid Treatments Be as Elusive for Poor Countries as Vaccines?
Merck has taken a step to make its antiviral pill [...]
Elizabeth Holmes Trial: Key Moments From Week 6
Testimony addressed the question of whether Theranos was misleading and [...]
A Racial Disparity in Schizophrenia Diagnoses in Nursing Homes
Diagnoses for the disorder have soared in the past decade, [...]
F.D.A. Panel Recommends Moderna Booster for Certain Groups
Those eligible for the extra shot would include adults over [...]
F.D.A. Panel Greenlights Moderna Boosters for High-Risk Individuals
A Food and Drug Administration advisory panel recommended a half-dose [...]
Merck Asks F.D.A. for Emergency Approval of Covid Pill
The company is seeking federal sign-off for the pill to [...]
Moderna, Racing for Profits, Keeps Covid Vaccine Out of Reach of Poor
Some poorer countries are paying more and waiting longer for [...]
Pfizer Asks F.D.A. to Authorize Its Covid-19 Vaccine for Children 5 to 11
The agency has promised to move quickly on the request [...]
With Biden’s Agenda in the Balance, Lobbying Kicks Into High Gear
Business interests are using ads and other efforts to cajole [...]
Study: Pfizer Vaccine Protects Against Hospitalization for Six Months
The findings, which also document a waning of protection against [...]